Clinical trial · Interventional
Radiofrequency Ablation Using Cooled-Wet Electrode
Switching Bipolar Radiofrequency Ablation Using Cooled-Wet Electrode for Treatment of Hepatocellular Carcinoma: A Preliminary Study
NCT02675894CI-TRIAL-00050729completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To determine safety, ablative zone, technical success rate and early safety data of recently introduced cool-wet electrode in eligible patients who are indicative for radiofrequency ablation (RFA) for liver tumors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HCC | — | UNRESOLVED | — |
| Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cooled-wet electrode | Device | — | UNRESOLVED |
| separable clustered electrode | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- RFA with cooled-wet electrode
- description
- RFA is performed using three cool-wet electrodes in switching bipolar mode under the fused US guidance.
- interventionNames
- Device: cooled-wet electrode
- type
- ACTIVE_COMPARATOR
- label
- RFA with separable clustered electrode
- description
- RFA using separable clustered electrode in switching monopolar mode under the fused US guidance
- interventionNames
- Device: separable clustered electrode
Primary outcomes (1)
- measure
- LTP
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: all conditions have to be fulfilled. * Diagnosed with HCC (1\~5cm) according to AASLD guideline or LI-RADS on MDCT or liver MRI within 60 days before RFA * liver metastasis histologically confirmed or characteristic findings on cross-sectional imaging * signed informed consent * treatment naive index tumor (no history of local treatment for an index tumor) Exclusion Criteria: * more than three tumors in a patients * tumor size larger than 5cm * tumor attaches to central portal vein or hepatic vein * Child-Pugh classification C * uncorrected coagulopathy * presence of extrahepatic metastases
References
Publications (0)
Data not yet available
No reference posted for this study.